top of page

Standard Operating Procedures

IBD Aware Standard Operating Procedures as of August 2024

IBD Aware Use Cases

EnLiSense products are not available for commercial distribution or use in the United States (IBD AWARE is only available under approved clinical study investigational device use conditions).

​

EnLiSense is a development stage technology company.

  • IBD Aware Instagram Page Icon
  • IBD Aware Facebook Page Icon
  • Enlisense LInkedin Page Icon

Learn more about IBD Aware

EnLiSense CCM is at the forefront of innovative health solutions, specializing in non-invasive, continuous monitoring of inflammatory biomarkers critical for managing chronic conditions like Crohn's disease and ulcerative colitis. Our advanced wearable technology provides real-time insights, empowering patients and healthcare professionals with data-driven support.

bottom of page